Detalhe da pesquisa
1.
Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.
Biochem Biophys Res Commun
; 513(2): 340-346, 2019 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30955858
2.
The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
BMC Cancer
; 19(1): 455, 2019 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31092221
3.
Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies.
J Obstet Gynaecol Res
; 42(7): 757-62, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27094348
4.
Poor prognosis of ovarian cancer with large cell neuroendocrine carcinoma: case report and review of published works.
J Obstet Gynaecol Res
; 40(3): 869-72, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24738132
5.
Laparoscopic ovarian-sparing surgery for a young woman with an exophytic ovarian fibroma.
J Obstet Gynaecol Res
; 39(12): 1610-3, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23875949
6.
Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report.
Mol Clin Oncol
; 13(2): 141-145, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32714537
7.
Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma.
J Immunother Cancer
; 8(1)2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32461346
8.
The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.
Oncoimmunology
; 6(8): e1338996, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28920005
9.
MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
Oncotarget
; 7(46): 75328-75338, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659536
10.
Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
PLoS One
; 10(6): e0128066, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26043110
11.
Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas.
PLoS One
; 10(7): e0132751, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26147301